RNAC 总资产历史(2016–2025)
Cartesian Therapeutics, Inc. (RNAC) 各财年年末总资产(来自 SEC 财报)。
$296.4MFY2025 · FY2016 以来:$89.3M → $296.4M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $296.4M | -31.9% |
| FY2024 | $435.0M | +42.6% |
| FY2023 | $305.1M | +83.9% |
| FY2022 | $165.9M | +3.8% |
| FY2021 | $159.9M | -3.4% |
| FY2020 | $165.4M | +66.2% |
| FY2019 | $99.6M | +123.8% |
| FY2018 | $44.5M | -56.0% |
| FY2017 | $101.1M | +13.2% |
| FY2016 | $89.3M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议